Effect of synthetic protease inhibitor gabexate mesilate on the attenuation of ischemia/reperfusion injury in canine kidney autotransplantation.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Surgery

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.SURG.2004.07.014PMID 15674204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats.

  2003cited by this paper
• Protective effects of inhaled nitric oxide and gabexate mesilate in lung reperfusion injury after transplantation from non-heart-beat donors.

  2002cited by this paper
• Attenuation of renal ischemia-reperfusion injury by FR167653 in dogs.

  2002cited by this paper
• A chiral HPLC method for the determination of low amounts of D-carnitine in L-carnitine after derivatization with (+)-FLEC.

  2002cited by this paper
• APOPTOSIS VERSUS NECROSIS DURING COLD STORAGE AND REWARMING OF HUMAN RENAL PROXIMAL TUBULAR CELLS1

  2001cited by this paper
• RENAL TUBULAR CELL NECROSIS AND APOPTOSIS IN TRANSPLANTED KIDNEYS

  2001cited by this paper
• ATTENUATION OF ISCHEMIA AND REPERFUSION INJURY OF CANINE LIVERS BY INHIBITION OF TYPE II PHOSPHOLIPASE A2 WITH LY3297221

  2001cited by this paper
• Effect of FR167653 on pancreatic ischemia-reperfusion injury in dogs.

  2001cited by this paper
• Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes.

  2001cited by this paper
• Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction.

  2000cited by this paper
• Pathophysiology of ischaemia–reperfusion injury

  2000cited by this paper
• Effect of Protease Inhibitor on Ischemia-reperfusion Injury to Rat Liver

  1999cited by this paper
• Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation.

  1999cited by this paper
• Role of microcirculation in hepatic ischemia/reperfusion injury.

  1999cited by this paper
• Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury.

  1999cited by this paper
• Protective effects of ONO-5046*Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury.

  1999cited by this paper
• Long-term Renal Function In Non-heart-beating Donor Kidney Transplantation: A Single-center Experience1

  1998cited by this paper
• Renal Ischemia – Reperfusion Injury: Contribution of Nitric Oxide and Renal Blood Flow

  1998cited by this paper
• Thrombin is an extracellular signal that activates intracellular death protease pathways inducing apoptosis in model motor neurons.

  1998cited by this paper
• Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas.

  1998cited by this paper
• Long-term renal function in on-heart-beating donor kidney transplantation: a single-center experience.

  1998cited by this paper
• Inhibitory effect of protease inhibitor on endothelial cell activation.

  1998cited by this paper
• Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.

  1998cited by this paper
• The nature of ischemia/reperfusion injury.

  1998cited by this paper
• Role of IL-1 in renal ischemic reperfusion injury.

  1998cited by this paper
• Frequent apoptosis in human kidneys after acute renal hypoperfusion.

  1997cited by this paper
• Macrophage TNF mRNA expression is modulated by protease inhibitors.

  1997cited by this paper
• Increased serum neutral endopeptidase activity in acute renal allograft rejection.

  1996cited by this paper
• Biologic basis for interleukin-1 in disease.

  1996cited by this paper
• Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury.

  1996cited by this paper
• Renal pathology : with clinical and functional correlations

  1993cited by this paper
• Apoptosis and cell desquamation in repair process of ischemic tubular necrosis

  1993cited by this paper
• Treatment of disseminated intravascular coagulation with gabexate mesilate.

  1993cited by this paper
• Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia.

  1992cited by this paper
• Effect of synthetic protease inhibitors on superoxide (O2-), hydrogen peroxide (H2O2) and hydroxyl radical production by human polymorphonuclear leukocytes.

  1992cited by this paper
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

  1992cited by this paper
• Tumor necrosis factor alpha and mesangial cells.

  1992cited by this paper
• Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse.

  1990cited by this paper
• Oxygen Free Radical Induced Damage in Kidneys Subjected to Warm Ischemia and Reperfusion: Protective Effect of Superoxide Dismutase

  1985cited by this paper
• Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine.

  1983cited by this paper
• AN EXPERIMENTAL MODEL FOR ASSESSMENT OF RENAL RECOVERY FROM WARM ISCHEMIA

  1983cited by this paper
• New approach to regional anticoagulation in hemodialysis using gabexate mesilate (FOY).

  1982cited by this paper
• Clonal analysis of F1 hybrid helper T cells. I-A subregion-encoded hybrid determinants restrict the activity of keyhole limpet hemocyanin- specific helper T cells

  1981cited by this paper
• FOY: [ethyl p-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. II. In vivo effect on coagulofibrinolytic system in comparison with heparin or aprotinin.

  1981cited by this paper
• FOY: [ethyl P-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. I. Inhibition of thrombin and factor Xa in vitro.

  1980cited by this paper

• Blackberry-Loaded AgNPs Attenuate Hepatic Ischemia/Reperfusion Injury via PI3K/Akt/mTOR Pathway

  2023cites this paper
• Comparison of the efficacy of continuous i.v. infusion versus continuous regional arterial infusion of nafamostat mesylate for severe acute pancreatitis

  2016cites this paper
• Preconditioning with gabexate is superior to inosine for ameliorating acute renal ischemia-reperfusion injury in rats.

  2014cites this paper
• Appraisal of the porcine kidney autotransplantation model

  2013cites this paper
• Effect of cell permeable peptide of c-Jun NH2-terminal kinase inhibitor on the attenuation of renal ischemia-reperfusion injury in pigs.

  2013cites this paper
• Noble Gas (Argon and Xenon)-Saturated Cold Storage Solutions Reduce Ischemia-Reperfusion Injury in a Rat Model of Renal Transplantation

  2012cites this paper
• Appraisal of the porcine kidney autotransplantation model.

  2012cites this paper
• Gabexate Mesilate Suppresses Influenza Pneumonia in Mice through Inhibition of Cytokines

  2008cites this paper
• TNFalpha in myocardial ischemia/reperfusion: damage vs. protection.

  2008cites this paper
• Current World Literature

  2006cites this paper
• Effects of gabexate mesilate on ischemia-reperfusion-induced testicular injury in rats

  2006cites this paper